Middle East & Africa Blood Irradiation Market

The blood irradiation market in the Middle East & Africa is expected to grow from US$ 1.62 million in 2022 to US$ 2.18 million by 2028. It is estimated to grow at a CAGR of 5.1% from 2022 to 2028. 

Technological Advancements and Product Launches to Introduce New Trends in Market

Trends in the healthcare sector are changing drastically with continuous technological developments and innovations, contributing to the enhancement of the quality of healthcare services and care. Various blood irradiation market players are operating regionally and striving to expand their market shares, followed by the rising demand for blood irradiation. They are investing significantly in research and development activities to introduce novel blood irradiation devices and technologies. There have been advancements in alternative technologies such as proton and ion beam therapies that use high-energy, positive ions and have high precision in treating tumors with reduced exposure to normal tissues. Moreover, FLASH radiotherapy, carbon ion therapy, volumetric-modulated arc therapy, and intensity-modulated radiotherapy treat solid tumors. These technological advancements have a high precision rate with reduced side effects. Thus, an increase in technological advancements, product launches, and the increasing use of alternative technologies are expected to support the growth of the Middle East & Africa blood irradiation market in the coming years.

Market Overview

The Middle East & Africa blood irradiation market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa. The market growth in this region is attributed to the increasing prevalence of communicable and noncommunicable diseases, growing number of research studies, an improvements in healthcare facilities. Additionally, Saudi Arabia is one of the important countries in the Middle Eastern region that has significant scope for the blood irradiation market. The healthcare system in the country is developing at rapid pace as well as increasing number of international companies are developing medical and research team in the country. A sharp increase in the state health budget is also expected to drive the growth of blood irradiation market in the country.

Middle East & Africa Blood Irradiation Market Revenue and Forecast to 2028 (US$ Million)

            Middle East & Africa Blood Irradiation Market Segmentation

The Middle East & Africa blood irradiation market is segmented into type, indication, end user, and country.

• Based on type, the market is segmented into intravenous laser blood irradiation, transcutaneous laser blood irradiation, and extracorporeal blood irradiation. The intravenous laser blood irradiation segment registered the largest market share in 2022.
• Based on indication, the market is segmented into acute leukemia, lymphoma, solid tumors, pelvic tumors and others. The acute leukemia segment held the largest market share in 2022.
• Based on end user, the market is segmented into hospitals, blood banks, diagnostics clinics, and research institutes. The hospital segment held the largest market share in 2022.
• Based on country, the market is segmented into UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa. Saudi Arabia dominated the market share in 2022.

Hitachi, Ltd.; Best Theratronics Ltd.; Gilardoni S.p.A.; Typenex Medical; and Actemium are the leading companies operating in the blood irradiation market in the Middle East & Africa.   

Middle East & Africa Blood Irradiation Market Strategic Insights

Middle East & Africa Blood Irradiation Market Segmentation Analysis

Middle East & Africa Blood Irradiation Market Report Highlights

Middle East & Africa Blood Irradiation Report Scope

Middle East & Africa Blood Irradiation Market Country and Regional Insights